Literature DB >> 29970331

Risk of Traumatic Brain Injury Among Children, Adolescents, and Young Adults With Attention-Deficit Hyperactivity Disorder in Taiwan.

Ying-Jay Liou1, Han-Ting Wei2, Mu-Hong Chen3, Ju-Wei Hsu4, Kai-Lin Huang4, Ya-Mei Bai4, Tung-Ping Su5, Cheng-Ta Li4, Albert C Yang4, Shih-Jen Tsai4, Wei-Chen Lin4, Tzeng-Ji Chen6.   

Abstract

PURPOSE: Previous studies suggested that patients with attention-deficit hyperactivity disorder (ADHD) were prone to health-risk behaviors and accidents. However, the relationship of ADHD with the risk of traumatic brain injury (TBI) remained uncertain.
METHODS: Using the Taiwan National Health Insurance Research Database, 72,181 children (aged 3-11 years), adolescents (12-17 years), and young adults (18-29 years) with ADHD and 72,181 age-/sex-matched controls were enrolled between 2001 and 2009, and followed up to the end of 2011 in our study. Those who developed any TBI during the follow-up period were identified.
RESULTS: Children, adolescents, and young adults with ADHD had a higher incidence of developing any TBI (9.8% vs. 2.2%, p < .001), such as skull fracture (.2% vs. .1%, p < .001) and concussion (4.3% vs. 1.0%, p < .001), than the controls did. Cox regression analysis with the adjustment of demographic data, psychiatric comorbidities, and ADHD medications showed that ADHD was related to an increased risk of subsequent TBI (hazard ratio: 4.57, 95% confidence interval: 4.31-4.85), and indicated that long-term use of ADHD medication was associated with a reduced likelihood of subsequent TBI (hazard ratio: .93, 95% confidence interval: .87-.99).
CONCLUSIONS: Patients with ADHD had an increased risk of developing any TBI compared with the controls. Long-term use of ADHD medications would reduce this risk. Our findings suggested that the public health government and clinicians should pay more attention to the TBI risk among patients with ADHD, and further indicated the importance of the optimal treatment for ADHD.
Copyright © 2018 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADHD; ADHD medications; Traumatic brain injury

Mesh:

Substances:

Year:  2018        PMID: 29970331     DOI: 10.1016/j.jadohealth.2018.02.012

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  12 in total

Review 1.  Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.

Authors:  Zheng Chang; Laura Ghirardi; Patrick D Quinn; Philip Asherson; Brian M D'Onofrio; Henrik Larsson
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

2.  Attention Deficit Hyperactivity Disorder (ADHD) in Patients with and without Head Trauma.

Authors:  Shahrokh Amiri; Elham Esmaeili; Firooz Salehpour; Farhad Mirzaei; Habibeh Barzegar; Aysan Mohammad Namdar; Homayoun Sadeghi-Bazargani
Journal:  Open Access Emerg Med       Date:  2020-11-17

3.  ADHD May Associate With Reduced Tolerance to Acute Subconcussive Head Impacts: A Pilot Case-Control Intervention Study.

Authors:  Madeleine K Nowak; Keisuke Ejima; Patrick D Quinn; Jeffrey J Bazarian; Timothy D Mickleborough; Jaroslaw Harezlak; Sharlene D Newman; Keisuke Kawata
Journal:  J Atten Disord       Date:  2020-11-07       Impact factor: 3.256

4.  Road-Crossing Behavior in Complex Traffic Situations: A Comparison of Children With and Without ADHD.

Authors:  Zahra Tabibi; David C Schwebel; Hamid Zolfaghari
Journal:  Child Psychiatry Hum Dev       Date:  2021-06-09

5.  Attention-Deficit/Hyperactivity Disorder and Mortality Risk in Taiwan.

Authors:  Vincent Chin-Hung Chen; Hsiang-Lin Chan; Shu-I Wu; Meng Lee; Mong-Liang Lu; Hsin-Yi Liang; Michael E Dewey; Robert Stewart; Charles Tzu-Chi Lee
Journal:  JAMA Netw Open       Date:  2019-08-02

6.  Prevalence of ADHD in Accident Victims: Results of the PRADA Study.

Authors:  Sarah Kittel-Schneider; Sarah Wolff; Kristin Queiser; Leonie Wessendorf; Anna Maria Meier; Moritz Verdenhalven; Nathalie Brunkhorst-Kanaan; Oliver Grimm; Rhiannon McNeill; Sascha Grabow; Christoph Reimertz; Christoph Nau; Michelle Klos; Andreas Reif
Journal:  J Clin Med       Date:  2019-10-08       Impact factor: 4.241

7.  Concussion Incidence and Recovery Among Youth Athletes With ADHD Taking Stimulant-Based Therapy.

Authors:  Muhammad Ali; Nickolas Dreher; Theodore Hannah; Adam Li; Nek Asghar; Zachary Spiera; Naoum Fares Marayati; John Durbin; Alex Gometz; Mark Lovell; Tanvir Choudhri
Journal:  Orthop J Sports Med       Date:  2021-10-08

8.  Adverse childhood experiences and traumatic brain injury among adolescents: findings from the 2016-2018 National Survey of Children's Health.

Authors:  Dylan B Jackson; Chad Posick; Michael G Vaughn; Alexander Testa
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-01-02       Impact factor: 4.785

9.  Methylphenidate and TBI in ADHD and co-occurring epilepsy and mental disorders: a self-controlled case series study.

Authors:  Vincent Chin-Hung Chen; Yao-Hsu Yang; Charles Tzu-Chi Lee; Yi-Lung Chen; Michael E Dewey; Michael Gossop
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-01-02       Impact factor: 4.785

10.  Treatment with Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of All-Cause Poisoning in Children and Adolescents: A Self-Controlled Case Series Study.

Authors:  Le Gao; Kenneth K C Man; Esther W Chan; Celine S L Chui; Xue Li; David Coghill; Kam Lun Hon; Man Li Tse; Terry Y S Lum; Kirstie H T W Wong; Patrick Ip; Ian C K Wong
Journal:  CNS Drugs       Date:  2021-07-20       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.